Effect of fremanezumab on quality of life and productivity in patients with chronic migraine

OBJECTIVE: To evaluate fremanezumab quarterly or monthly vs placebo on health-related quality of life, health status, patients' global impression of change, and productivity in patients with chronic migraine (CM). METHODS: HALO CM was a double-blind, placebo-controlled trial in patients with CM...

Descripción completa

Detalles Bibliográficos
Autores principales: Lipton, Richard B., Cohen, Joshua M., Gandhi, Sanjay K., Yang, Ronghua, Yeung, Paul P., Buse, Dawn C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605497/
https://www.ncbi.nlm.nih.gov/pubmed/32747522
http://dx.doi.org/10.1212/WNL.0000000000010000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605497/
https://www.ncbi.nlm.nih.gov/pubmed/32747522
http://dx.doi.org/10.1212/WNL.0000000000010000

Ejemplares similares